Sievert DM,Ricks P,Edwards JR,et al.Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections:Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention,2009-2010[J].Infect Control Hosp Epidemiol,2013,34(1):1-14.
[2]
应妩,毓三,子瑜,等.全国临床检验操作规程[M].南京:东南大学出版社,2006:615-620.Ying W,Yu S,Zi Y,et al.National guide to clinical laboratory procedures[M].Southeast University Press,2006:615-620.
[3]
Patel JB,Cockerill FR,Alder J,et al.Performance standards for antimicrobial susceptibility testing:twenty-fourth informational supplement[M].Wayne:Clinical and Laboratory Standards Institute,2014:347-362.
[4]
谢强,曹明杰,陈玲,等.2013年血培养病原菌分布与耐药性分析[J].中华医院感染学杂志,2015,(12):2 687-2 688,2 703.Xie Qiang,Cao MJ,Chen Ling,et al.Distribution and drug resistance of pathogens isolated from blood culture from in2013[J].Chin J Nosoeomiol,2015,(12):2 687-2 688,2 703.
Daikos GL,Tsaousi S,Tzouvelekis LS,et al.Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections:Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems[J].Antimicrob Agents Chemother,2014,58(4):2 322-2 328.
[7]
王世瑜,刘晔华,张坚磊,等.血培养常见病原菌分布及耐药性分析[J].中华医院感染学杂志,2014,24(1):39-41.Wang SY,Liu YH,Zhang JL,et al.Distribution and drug resistance of pathogens from blood culture samples[J].Chin J Nosoeomiol,2014,24(1):39-41.
Tzouvelekis LS,Markogiannakis A,Psichogiou M,et al.Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae:an Evolving Crisis of Global Dimensions[J].Clin Microbiol Rev,2012,25(4):682-707.
Wisplinghoff H,Ebbers J,Geurtz L,et al.Nosocomial bloodstream infections due to Candida spp.in the USA:species distribution,clinical features and antifungal susceptibilities[J].Int J Antimicrob Agents,2014,43(1):78-81.
